This is a prospective, multicenter, randomized, active controlled, clinical trial to evaluate the safety and effectiveness of the LAMax Left Atrial Appendage (LAA) Closure System.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Successful sealing of the LAA
Timeframe: 12 months post-implantation
Ischemic stroke, TIA, or Systemic embolism
Timeframe: 12 months post-implantation